RSS   Newsletter   Contact   Advertise with us

InMed Pharmaceuticals appoints Adam Cutler to board

Staff writer | Vancouver, BC, Canada | November 24, 2015
InMed PharmaceuticalsNovember 24, 2015, Vancouver, BC, Canada - InMed Pharmaceuticals, a biopharmaceutical company, announced that it has has appointed Adam Cutler to the board.
Mr. Cutler is currently senior vice-president of corporate affairs at Arbutus Biopharma, and previously was a managing director at The Trout Group and Trout Capital.

Mr. Cutler spent almost 12 years as a sell-side analyst with firms including Credit Suisse, Canaccord Genuity, JMP Securities and Bank of America Securities, with prior analytical and consulting experience at The Frankel Group and Ernst & Young, health care consulting.

Mr. Cutler holds a BA in economics from Brandeis University.


 LATEST MOVES FROM British Columbia 


MORE INSIDE POST